Drawing for Serial No. 79003529

USPTO serial 79003529

Serial No. 79003529

Reviewed by CopyMark Law Group

Reg. 3073701Status 404
Filing date
Status date
Registration date
Mar 28, 2006
Examiner
BUONGIORNO, CHRISTOPHER L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79003529?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005antibiotics, antibiotics, antiallergic medicines, antibacterial substances for medical purposes, anticonvulsants, antidepressants, antidiabetic preparations, antipyretic analgesics, anti-cough drops, anti-infective products for veterinary use, bronchial dilators, synthetic narcotics, bacteriostats for medicinal, dental and veterinary use; acne medications; acne medications, acne treatment preparations, adjuvants for use with vaccines, allergy medications, anesthetics for non-surgical use, anesthetics for surgical use, anesthetics for surgical and non-surgical use, anthelmintics, antipyretic analgesics, anti-itch cream, anti-itch ointment, bacterial and bacteriological preparations for medical or veterinary purposes, blood substitute for human, diuretics, medicated bath preparations, medicated lotions for skin, medicated skin care preparations, biochemical preparations for medical or veterinary purposes, pharmaceutical products and preparations for hydrating the skin during pregnancy, topical anesthetics, pharmaceutical preparations for the treatment of headaches; pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, pharmaceutical for the treatment of erectile dysfunction, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparation for the treatment of gout, pharmaceutical preparations for the treatment ofheart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for animal skincare, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds, pharmaceutical products and preparations against dry skin caused by pregnancy, pharmaceutical products and preparations for chloasma, pharmaceutical products and preparations for hydrating the skin during pregnancy, pharmaceutical products and preparations for pregnancy blemishes, pharmaceutical products and preparations for preventing skin blemishes during pregnancy, pharmaceutical products and preparations to prevent stretch marks, pharmaceutical products and preparations to prevent swelling in the legs, pharmaceutical products for ophthalmological use, pharmaceutical products for skin care for animals, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical skin lotions pharmaceutical solutions used in dialysis, antibacterial Pharmaceuticals, anti-diabetic Pharmaceuticals, astringents pharmaceutical, cardiovascular Pharmaceuticals, dermatological pharmaceutical products; biological preparations for medical purposes, biological and chemical preparations and reagents for medical or veterinary use; ferments for medical or veterinary use, topical anesthetics, sanitary sterilising preparations, veterinary vaccines, all-purpose disinfectants, chemical conductors for use with electrocardiograph electrodes, chemical preparations for sanitary purposes, chemotherapeutics, chloramphenicol preparations, cholesterol reducers, chondroitin preparations, dermatological s, diagnostic preparations for clinical or medical laboratory use, diagnostic preparations for medical and veterinary use, diagnostic reagents for medicinal use, disinfectants for medical instruments, disinfectants for sanitary purposes, parasiticides for medical use, reagents and media for medical and veterinary diagnostic purposes; amino acids for medical or veterinary purposes, analgesic balm, analgesic preparations, analgesics, ear drops, emetic preparations, fongal medications, preparations for the treatment of chilblain, anti-dermoinfectives, nose drops, synthetic peptides for pharmaceutical purposes, vitamin and mineral preparations for use as ingredients in the pharmaceutical industry, sunburn preparations for pharmaceutical purposesSECTION 71 - CANCELLED—
035conducting marketing studies; import and export agencies; sales promotion for others, namely, provided through the distribution and the administration of privileged user cards; publicity servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2014DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Sep 11, 2014DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 13, 2014INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 14, 2014INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 30, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 30, 2013C71TCANCELLED SECTION 71—
Mar 7, 2008CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 2, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 25, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 25, 2006FIMPFINAL DISPOSITION PROCESSED—
Oct 19, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 28, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 2, 2006ISIRWITHDRAWN FROM ISSUE - TQR/NON-ATTY REQUEST—
Jan 19, 2006OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 29, 2005OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 29, 2005OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 6, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 16, 2005NPUBNOTICE OF PUBLICATION—
Oct 18, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 7, 2005ALIEASSIGNED TO LIE—
Oct 3, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2005CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 18, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 29, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 28, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 25, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 25, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 25, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 14, 2004RFNTREFUSAL PROCESSED BY IB—
Sep 14, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2004DOCKASSIGNED TO EXAMINER—
Aug 2, 2004NWAPNEW APPLICATION ENTERED—
Jul 29, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance